Prosecution Insights
Last updated: April 19, 2026

Examiner: HAYMAN, IMANI N

Tech Center 4100 • Art Units: 2841 3763 3767 3783 4100 4169

This examiner grants 72% of resolved cases

Performance Statistics

71.5%
Allow Rate
+11.5% vs TC avg
727
Total Applications
+25.5%
Interview Lift
1304
Avg Prosecution Days
Based on 722 resolved cases, 2023–2026

Rejection Statute Breakdown

0.7%
§101 Eligibility
30.8%
§102 Novelty
45.4%
§103 Obviousness
16.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18373805 Connection Systems and Methods Thereof Non-Final OA Bard Access Systems, Inc.
18385655 Adaptor for a Drug Delivery Device and Drug Delivery Device Non-Final OA Becton Dickinson France
18141310 MULTI-COMPONENT BIO-ACTIVE DRUG DELIVERY AND CONTROLLED RELEASE TO THE SKIN BY MICRONEEDLE ARRAY DEVICES Non-Final OA University of Pittsburgh - Of the Commonwealth System of Higher Education
18359969 Needle-Free Injection System Non-Final OA NovaXS Biotech Corp.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month